• Takeda director and President, R&D Andrew Stewart Plump sold 19,651 American Depositary Shares on Aug. 19 at USD 18.49.
• Trust-held stake fell to 261,656 ADS; direct holdings listed at 766,569 ADS.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Takeda Pharmaceutical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039693), on August 21, 2026, and is solely responsible for the information contained therein.